Discover the newest research about AI innovations in ๐งช Drug Discovery.
ChatGPT enhances drug harm reviews: 49% keyword recreation, 0.17 Jaccard similarity. Effective error detection tool! ๐๐
National Taiwan University Hospital introduces AI for pancreatic cancer imaging, enhancing early detection and diagnostic accuracy. ๐ฅ๐ป
Generative AI is enhancing drug development efficiency. The DiffSMol model shows a 61.4% success rate in creating promising drug candidates. ๐โจ
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. ๐ค๐
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. ๐๐
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. ๐ง ๐
Machine learning reveals 11 hub biomarkers for coronary artery disease, highlighting ITM2B’s potential role in inflammation. ๐ซ๐ฌ
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ๐๐ค
Deep learning enhances sonosensitizer-drug co-assembly, achieving 90% precision and 96% recall for cancer therapy. ๐ก๐ฌ
Klebsiella pneumoniae’s rising virulence and antibiotic resistance pose significant health risks. ๐ฆ ๐ Explore novel therapeutic strategies!
